Bioscience Reports · 2019 · 21 citations · 27 references
Life SciencesCell BiologyMolecular BiologyCell SignalingMetastasisSignal TransductionCancer ProgressionEndometrial CancerEpithelial-mesenchymal TransitionEpithelial-to-mesenchymal TransitionMicrorna BiologyMicrorna-mediated RegulationDual-luciferase AssaysEpithelial-mesenchymal Transition In CancerEpithelial-mesenchymal Transition MarkersLuciferase Reporter AssaysLuciferase ReportersMicrorna In CancerMicrorna Regulation Of EmtVimentin Expression
Recently, many mircroRNAs (miRNAs) involved in the development and progression of cancer have been reported to regulate cell growth and metastasis, including microRNA-202 (miR-202). The purpose of the present study was to elucidate the effect of miR-202 on endometrial carcinoma (EC) cell migration and invasion. First, qRT-PCR showed that miR-202 was down-regulated in EC tissues, which was associated with poor prognosis in EC patients. Functionally, transwell assay indicated that miR-202 inhibited cell migration and invasion in EC cells. In addition, miR-202 also blocked epithelial-mesenchymal transition (EMT) through suppressing N-cadherin and Vimentin expressions and promoting E-cadherin expression. Moreover, the dual-luciferase reporter assay showed that fibroblast growth factor 2 (FGF2) is a direct target gene for miR-202 in EC cells. Furthermore, up-regulation of FGF2 attenuated the inhibitory effect of miR-202 on cell migration and invasion in EC. Besides that, miR-202 inactivated the Wnt/β-catenin signaling by suppressing β-catenin expression in EC. In conclusion, miR-202 inhibited cell migration and invasion by targeting FGF2 and inactivating the Wnt/β-catenin signaling in EC.
27
miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer
Ye Hu, Yufan Qiu, Ernesto Yagüe et al. · Cell Death and Disease · 2016 · 134 citations · Full text
Medicine, Oncology, Pharmacology +16
miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells
Chunhui Liu, Han Guan, Yiduo Wang et al. · PLoS ONE · 2015 · 93 citations · Full text
Medicine, Cancer Biology, Oncology +17